Release Date: 31/01/12 11:04 Summary: Boardroom Radio Interview Price Sensitive: No Download Document 97.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%